Co-Analyst Research

Research Notes & Thematic Analysis

Co-Analyst driven research on thematic trends, public companies and competitive landscapes.

AB InBev Q2 2026 Earnings Preview: BUD Revenue Preview

AB InBev (BUD) Q2 2026 earnings preview highlights $16.3B revenue estimate and strong growth in Beyond Beer and digital platforms.

AbbVie Q2 2026 earnings preview: guidance raised, immunology and neuroscience segments lead growth. See key numbers and what to watch.

Altria (MO) Q2 2026 earnings preview: consensus sees $5,351M revenue, $1.49 EPS. Key focus on smokeable trends and on! PLUS rollout.

Amphenol (APH) Q2 2026 earnings preview: strong revenue growth, CCS integration, and margin trends to watch.

Apple (AAPL) Q3 2026 earnings preview highlights strong iPhone 17 demand and 16% revenue growth. See key metrics and guidance.

ARM Holdings (ARM) Q1 2026 earnings preview highlights 20% revenue growth, AGI CPU ramp, and strong data center momentum.

BBVA Q2 2026 earnings preview highlights $3.3B net income consensus and strong loan growth in Mexico and Spain.

Bristol Myers Squibb Q2 2026 earnings preview: guidance, consensus, and key growth drivers including Eliquis and Camzyos.

Chevron (CVX) is expected to post a sharp Q2 2026 earnings rebound, with revenue forecast at $59.7B and strong production growth.